Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients

Recruiting now · Not applicable

Conditions studied: Post COVID-19 Condition, Post COVID-19 Condition (PCC), Post COVID-19, Post COVID-19 Syndrome, Long COVID-19 Syndrome

In brief

This randomized controlled study evaluates the effects of cold water hydrotherapy in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to an usual care setting without hydrotherapy treatment.

Key facts

Study ID

NCT07110714

Run by

Eggensberger OHG

People needed

30

Starts

2025-12-01

Expected to finish

2027-10-31

Last updated by the study team

2025-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9)
• Barthel-Index >80
• Owning a smartphone to receive digital questionnaires and to use the measurement app for heart rate variability
• Written informed consent

You may not qualify if…

• Existing contraindications for Kneipp hydrotherapy like severe cardiovascular diseases (e.g., decompensated heart failure, unstable angina pectoris, acute myocardial infarction), severe venous diseases (e.g., acute deep vein thrombosis of the leg), severe neurological diseases (e.g., uncontrolled epilepsy)
• Prior regular practice of Kneipp applications

Where it is running

• Eggensberger Ohg — Füssen, Bavaria, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.